Eichhorn, M. E., Niedermaier, B. W., Charoentong, P., Klotz, L. V., Baum, P., Griffo, R., . . . Eichhorn, F. (2025). Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: Results of the NEOMUN trial. Journal for ImmunoTherapy of Cancer, 13(8), . https://doi.org/10.1136/jitc-2025-011874
Chicago-Zitierstil (17. Ausg.)Eichhorn, Martin E., et al. "Neoadjuvant Anti-programmed Death-1 Immunotherapy by Pembrolizumab in Resectable Non-small Cell Lung Cancer: Results of the NEOMUN Trial." Journal for ImmunoTherapy of Cancer 13, no. 8 (2025). https://doi.org/10.1136/jitc-2025-011874.
MLA-Zitierstil (9. Ausg.)Eichhorn, Martin E., et al. "Neoadjuvant Anti-programmed Death-1 Immunotherapy by Pembrolizumab in Resectable Non-small Cell Lung Cancer: Results of the NEOMUN Trial." Journal for ImmunoTherapy of Cancer, vol. 13, no. 8, 2025, https://doi.org/10.1136/jitc-2025-011874.